{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:13:59Z","timestamp":1792174439414,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"COHEAHR Network","award":["603019"],"award-info":[{"award-number":["603019"]}]},{"name":"CANCON"},{"DOI":"10.13039\/100000054","name":"US National Cancer Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jcv.2015.11.015","type":"journal-article","created":{"date-parts":[[2015,11,28]],"date-time":"2015-11-28T07:52:46Z","timestamp":1448697166000},"page":"S49-S55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":288,"special_numbering":"S1","title":["Triage of HPV positive women in cervical cancer screening"],"prefix":"10.1016","volume":"76","author":[{"given":"Nicolas","family":"Wentzensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Arbyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2015.11.015_bib0005","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","article-title":"Trends of cervical cancer mortality in the member states of the European Union","volume":"45","author":"Arbyn","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jcv.2015.11.015_bib0010","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(87)92695-X","article-title":"Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes","volume":"1","author":"Laara","year":"1987","journal-title":"Lancet (Lond. Engl.)"},{"key":"10.1016\/j.jcv.2015.11.015_bib0015","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet (Lond. Engl.)"},{"key":"10.1016\/j.jcv.2015.11.015_bib0020","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"Schiffman","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jcv.2015.11.015_bib0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1158\/1940-6207.CAPR-11-0542","article-title":"Reducing HPV-associated cancer globally","volume":"5","author":"Lowy","year":"2012","journal-title":"Cancer Prev. Res. (Phila. Pa)"},{"key":"10.1016\/j.jcv.2015.11.015_bib0035","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2015.11.015_bib0040","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1128\/JCM.01013-15","article-title":"Head-to-head comparison of the RNA-based aptima human papillomavirus (HPV) assay and the DNA-based hybrid capture 2HPV test in a routine screening population of women aged 30\u201360 years in Germany","volume":"53","author":"Iftner","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0045","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/ijc.24774","article-title":"How to evaluate emerging technologies in cervical cancer screening?","volume":"125","author":"Arbyn","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.11.015_bib0050","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.jcv.2015.11.015_bib0055","first-page":"973","article-title":"Where is the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses","volume":"91","author":"Kinney","year":"1998","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0060","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2007.07.049","article-title":"Risk assessment to guide the prevention of cervical cancer","volume":"197","author":"Castle","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0065","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9378(03)00413-7","article-title":"A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations","volume":"188","author":"ASCUS-LSIL Triage Study (ALTS) Group","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0070","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0002-9378(03)00418-6","article-title":"Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance","volume":"188","author":"ASCUS-LSIL Triage Study (ALTS) Group","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests","volume":"11","author":"Wright","year":"2007","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.jcv.2015.11.015_bib0080","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition?summary document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0085","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/bjc.2011.326","article-title":"HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the sentinel sites study","volume":"105","author":"Kelly","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jcv.2015.11.015_bib0090","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/LGT.0b013e318285423c","article-title":"Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines","volume":"17","author":"Katki","year":"2013","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.jcv.2015.11.015_bib0095","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/bjc.2011.351","article-title":"Use of HC2 to triage women with borderline and mild dyskaryosis in the UK","volume":"105","author":"Arbyn","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jcv.2015.11.015_bib0100","first-page":"147","article-title":"American cancer society, american society for colposcopy and cervical pathology, and american society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.jcv.2015.11.015_bib0105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/LGT.0b013e3181bbb62e","article-title":"Cervical neoplasia guidelines: United States and europe compared","volume":"14","author":"Stampler","year":"2010","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.jcv.2015.11.015_bib0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(14)70073-7","article-title":"Filling a gap in cervical cancer screening programmes","volume":"15","author":"Wentzensen","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0115","article-title":"European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination","author":"Karsa","year":"2015","journal-title":"Papillomavirus Res."},{"issue":"Suppl. 5","key":"10.1016\/j.jcv.2015.11.015_bib0120","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2015.11.015_bib0125","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jcv.2015.11.015_bib0130","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008054.pub2","article-title":"Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions","volume":"3","author":"Arbyn","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jcv.2015.11.015_bib0135","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/annonc\/mdt538","article-title":"Cervical cancer screening: on the way to a shift from cytology to full molecular screening","volume":"25","author":"Dijkstra","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0140","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju423","article-title":"Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial","volume":"107","author":"Bergeron","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jcv.2015.11.015_bib0145","doi-asserted-by":"crossref","DOI":"10.1002\/cncy.21596","article-title":"HPV DNA testing with cytology triage in cervical cancer screening: influence of revealing HPV infection status","author":"Richardson","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0155","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/1055-9965.EPI-11-0206","article-title":"A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser cohort study","volume":"20","author":"Schiffman","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jcv.2015.11.015_bib0160","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0165","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1055-9965.EPI-13-0173","article-title":"Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy","volume":"23","author":"Dijkstra","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jcv.2015.11.015_bib0175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1309\/AJCPLCD8TTOMLJTB","article-title":"Detection of human papillomavirus 16, 18, and 45 in women with ASC-US cytology and the risk of cervical precancer: results from the CLEAR HPV study","volume":"143","author":"Castle","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0180","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ygyno.2010.04.013","article-title":"Clinical validation of the cervista HPV HR and 16\/18 genotyping tests for use in women with ASC-US cytology","volume":"118","author":"Einstein","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1309\/AJCP53KMHNRDICBL","article-title":"Clinical performance of the BD Onclarity HPV assay using an adjudicated cohort of BD SurePath liquid-based cytology specimens","volume":"142","author":"Wright","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0190","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1128\/JCM.00176-14","article-title":"Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy","volume":"52","author":"Einstein","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0195","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/JCM.00633-13","article-title":"Clinical validation of the abbott realtime high risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening","volume":"51","author":"Hesselink","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0200","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jcv.2015.11.015_bib0205","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/AOG.0000000000000458","article-title":"Relevance of random biopsy at the transformation zone when colposcopy is negative","volume":"124","author":"Huh","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0210","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/ijc.28900","article-title":"The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments","volume":"136","author":"Bergeron","year":"2015","journal-title":"Int. J. Cancer J. Int. Cancer"},{"key":"10.1016\/j.jcv.2015.11.015_bib0215","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1470-2045(08)70208-0","article-title":"Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial","volume":"9","author":"Carozzi","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1470-2045(12)70529-6","article-title":"Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial","volume":"14","author":"Carozzi","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0225","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","article-title":"Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population","volume":"18","author":"Wentzensen","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jcv.2015.11.015_bib0230","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/cncy.21473","article-title":"Interobserver reproducibility and accuracy of p16\/Ki-67 dual-stain cytology in cervical cancer screening","volume":"122","author":"Wentzensen","year":"2014","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0235","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/cncy.21511","article-title":"Interpretation of p16(INK4a)\/Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology","volume":"123","author":"Allia","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0240","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","article-title":"Triaging pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 dual-stained cytology","volume":"121","author":"Petry","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0245","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv257","article-title":"p16\/Ki -67 dual stain cytology for detection of cervical precancer in HPV-positive women","volume":"107","author":"Wentzensen","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jcv.2015.11.015_bib0250","first-page":"109","article-title":"A virtual microscopy system to scan, evaluate and archive biomarker enhanced cervical cytology slides","volume":"32","author":"Grabe","year":"2010","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0255","doi-asserted-by":"crossref","first-page":"e61441","DOI":"10.1371\/journal.pone.0061441","article-title":"Semantic focusing allows fully automated single-layer slide scanning of cervical cytology slides","volume":"8","author":"Lahrmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2015.11.015_bib0260","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/ijc.28138","article-title":"CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease","volume":"133","author":"Bierkens","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.11.015_bib0265","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/jclinpath-2014-202616","article-title":"CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer","volume":"67","author":"De Strooper","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0270","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1470-2045(14)70019-1","article-title":"Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial","volume":"15","author":"Verhoef","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0275","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/1940-6207.CAPR-14-0237","article-title":"Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2\/3 lesions","volume":"7","author":"De Strooper","year":"2014","journal-title":"Cancer Prev. Res. (Phila. Pa)"},{"key":"10.1016\/j.jcv.2015.11.015_bib0280","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ygyno.2014.02.001","article-title":"Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women","volume":"132","author":"Vasiljevic","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0285","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/jnci\/djs425","article-title":"Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3","volume":"104","author":"Wentzensen","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jcv.2015.11.015_bib0290","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1158\/1055-9965.EPI-12-0905","article-title":"Human papillomavirus DNA methylation as a potential biomarker for cervical cancer","volume":"21","author":"Clarke","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jcv.2015.11.015_bib0295","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/jnci\/djs135","article-title":"Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population","volume":"104","author":"Mirabello","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jcv.2015.11.015_bib0300","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","article-title":"Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis","volume":"15","author":"Arbyn","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0305","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1158\/1940-6207.CAPR-13-0091","article-title":"An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China","volume":"6","author":"Zhao","year":"2013","journal-title":"Cancer Prev. Res. (Phila. Pa)"},{"key":"10.1016\/j.jcv.2015.11.015_bib0310","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/ijc.28616","article-title":"Lower cost strategies for triage of human papillomavirus DNA-positive women","volume":"134","author":"Qiao","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.11.015_bib0315","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ygyno.2013.06.005","article-title":"Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results","volume":"130","author":"Luhn","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0320","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/dc.22944","article-title":"Performance of ProEx C and PreTect HPV-proofer E6\/E7 mRNA tests in comparison with the hybrid capture 2HPV DNA test for triaging ASCUS and LSIL cytology","volume":"41","author":"Alaghehbandan","year":"2013","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0325","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ijc.27636","article-title":"The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy","volume":"132","author":"Arbyn","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.11.015_bib0330","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2217\/fmb.11.87","article-title":"Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts","volume":"6","author":"Sahasrabuddhe","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0335","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2014.55.9948","article-title":"Multiple biopsies and detection of cervical cancer precursors at colposcopy","volume":"33","author":"Wentzensen","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jcv.2015.11.015_bib0340","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-59745-423-0_15","article-title":"Cervical cytology biobanks as a resource for molecular epidemiology","volume":"675","author":"Arbyn","year":"2011","journal-title":"Methods Mol. Biol. (Clifton, N. J.)"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215007490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215007490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T06:24:35Z","timestamp":1537165475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653215007490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":68,"alternative-id":["S1386653215007490"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2015.11.015","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triage of HPV positive women in cervical cancer screening","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2015.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}